Cephalon, Takeda ramp up Provigil reps
Cephalon and Takeda Pharmaceuticals' North American divisions have entered into a deal that has more than doubled the size of the sales force promoting Cephalon's narcolepsy treatment Provigil.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.